The nuclear speckles protein SRRM2 is a new therapeutic target molecule on the surface of cancer cells
Markus Kellner, Julia Hörmann, Susanne Fackler, Yuanyu Hu, Tielin Zhou, Lin Lü, İbrahim Ilik, Tuğçe Aktaş, Regina Feederle, Stefanie M. Hauck, Olivier Gires, Kathrin Gärtner, Lietao Li, Reinhard Zeidler
The paper identifies SRRM2 as a surface-exposed cancer target and shows its utility in CAR-T cell therapy.
Cells · Sep 17, 2024Peer-reviewedCancer Biology